Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318306-10-000050
Filing Date
2010-05-17
Accepted
2010-05-17 14:21:27
Documents
5
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a10q-033110.htm 10-Q 537969
2 CEO CERTIFICATION ex_31-1.htm EX-31.1 17384
3 CFO CERTIFICATION ex_31-2.htm EX-31.2 17401
4 CEO CERTIFICATION ex_32-1.htm EX-32.1 6171
5 CFO CERITIFICATION ex_32-2.htm EX-32.2 6182
  Complete submission text file 0000318306-10-000050.txt   586726
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 10837590
SIC: 2834 Pharmaceutical Preparations